Nvidia scrutiny continues as smaller AI startups assess risks
The fallout from scrutiny surrounding Nvidia is being watched by smaller artificial intelligence companies that operate farther down the technology supply chain. Michal Miernowski, co-founder and CEO of Amperos Health, said his company, which develops AI agents for healthcare billing, is separated from Nvidia by roughly two layers of applied AI activity. He does not expect the company to be affected directly because it uses both leading AI models and open-source systems.
Miernowski nevertheless said a broader slowdown in the AI market could hinder the business. Such a cooling could result from concerns about Nvidia or from wider doubts about the sector, according to the report. Further developments involving Nvidia are expected, including the company’s investigation into actions by CEO, co-founder, and president Jensen Huang, as well as inquiries by Congress.
Evan Gotlob, a partner at DarrowEverett LLP and former state and federal prosecutor, said he believed there was more to examine regarding possible information leaks to China and questionable chip transactions. He said the board’s investigation would continue after his departure and was unlikely to produce a favorable outcome for Huang.
Written by Sakhanda Wire AI from reporting by The Verge. Facts, quotes and full context are in the original article below.